These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2565981)

  • 1. Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation.
    Romanin C; Kukovetz WR
    J Mol Cell Cardiol; 1989 Jan; 21(1):41-8. PubMed ID: 2565981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of nitrate-induced vasodilatation and tolerance.
    Kukovetz WR; Holzmann S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S9-14. PubMed ID: 1972361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of vasodilation by nitrates: role of cyclic GMP.
    Kukovetz WR; Holzmann S; Romanin C
    Cardiology; 1987; 74 Suppl 1():12-9. PubMed ID: 2886220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of vasodilation by molsidomine.
    Kukovetz WR; Holzmann S
    Am Heart J; 1985 Mar; 109(3 Pt 2):637-40. PubMed ID: 2983523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of nitrates with regard to vasodilatation and tolerance.
    Kukovetz WR; Holzmann S
    Z Kardiol; 1986; 75 Suppl 3():8-11. PubMed ID: 2879392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance and cross-tolerance between SIN-1 and nitric oxide in bovine coronary arteries.
    Kukovetz WR; Holzmann S
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S40-6. PubMed ID: 2484698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of soluble coronary arterial guanylate cyclase by SIN-1.
    Schmidt K; Kukovetz WR
    Eur J Pharmacol; 1986 Mar; 122(1):75-9. PubMed ID: 2869962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical tolerance to nitroglycerin is due to impaired biotransformation of nitroglycerin and biological counterregulation, not to desensitization of guanylate cyclase.
    Mülsch A; Busse R; Bassenge E
    Z Kardiol; 1989; 78 Suppl 2():22-5; discussion 64-7. PubMed ID: 2573982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
    Henry PJ; Horowitz JD; Louis WJ
    J Pharmacol Exp Ther; 1989 Feb; 248(2):762-8. PubMed ID: 2563771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of nitrate-induced vasodilation and tolerance.
    Kukovetz WR; Holzmann S
    Z Kardiol; 1983; 72 Suppl 3():14-9. PubMed ID: 6141677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses.
    Mülsch A; Busse R; Bassenge E
    Eur J Pharmacol; 1988 Dec; 158(3):191-8. PubMed ID: 2908105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic GMP as the mediator of molsidomine-induced vasodilatation.
    Kukovetz WR; Holzmann S
    Eur J Pharmacol; 1986 Mar; 122(1):103-9. PubMed ID: 3007172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between hydralazine and nitrovasodilators in vascular smooth muscle.
    Unger P; Berkenboom G; Fontaine J
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):478-83. PubMed ID: 7681511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanylate cyclase activation by organic nitrates is not mediated via nitrite.
    Romanin C; Kukovetz WR
    J Mol Cell Cardiol; 1988 May; 20(5):389-96. PubMed ID: 2905390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium- and sydnonimine-induced responses of native and cultured aortic smooth muscle cells are not impaired by nitroglycerin tolerance.
    Mülsch A; Busse R; Winter I; Bassenge E
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):568-74. PubMed ID: 2570362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nicorandil-induced relaxation, elevations of cyclic guanosine monophosphate and stimulation of guanylate cyclase with organic nitrate esters.
    Greenberg SS; Cantor E; Ho E; Walega M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1061-71. PubMed ID: 1679847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous modification of nitrovasodilator-induced cyclic GMP formation in human lymphocytes.
    Vuorinen P
    Pharmacol Toxicol; 1992 Jun; 70(6 Pt 1):463-7. PubMed ID: 1359526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyceryl trinitrate-induced desensitization of guanylate cyclase in cultured rat lung fibroblasts.
    Schröder H; Leitman DC; Bennett BM; Waldman SA; Murad F
    J Pharmacol Exp Ther; 1988 May; 245(2):413-8. PubMed ID: 2452870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP in nicorandil-induced vasodilatation and tolerance development.
    Kukovetz WR; Holzmann S
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S25-30. PubMed ID: 2447421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.